Plasma-transforming growth factor-alpha expression in residents of an arseniasis area in Taiwan

References

• Ahsan H, Perrin M, Rahman A, Parvez F, Stute M, Zheng Y, Milton AH, Brandt-Rauf P, Van Geen A, Graziano J. Associations between drinking water and urinary arsenic levels and skin lesions in Bangladesh. Journal of Occupation and Environmental Medicine 2000; 42: 1195–1201
   PubMed Web of Science ®Google Scholar
• Amundadottir LT, Nass SJ, Berchem GJ, Johnson MD, Dickson M. Cooperation of TGF-a and c-myc in mouse mammary tumorigenesis coordinated stimulation of growth and suppression of apoptosis. Oncogene 1996; 13: 757–765
   PubMed Web of Science ®Google Scholar
• Brandt-Rauf P. W. The c-erbB transmembrane growth factor receptors as serum biomarkers in human cancer studies. Mutation Research 1995; 333: 203–208
   PubMed Web of Science ®Google Scholar
• Brissenden JE, Deryneck R, Francke U. Mapping of transforming growth factor alpha gene on human chromosome 2 close to the breakpoint of the Burkitt's lymphoma t(2;8) variant translocation. Cancer Research 1985; 45: 5593–5597
   PubMed Web of Science ®Google Scholar
• Brown JL, Kitchin KT. Arsenic but not cadmium induces ornithine decarboxylase and heme oxygenase activity in rat liver, relevance to arsenic carcinogenesis. Cancer Letters 1996; 98: 227–231
   PubMed Web of Science ®Google Scholar
• Chen CJ, Chen CW, Wu MM, Kuo TL. Cancer potential in liver, lung, bladder, and kidney due to ingested inorganic arsenic in drinking water. British Journal of Cancer 1992; 66: 888–892
   PubMed Web of Science ®Google Scholar
• Chen CJ, Chiou HY, Chiang MH, Lin LJ, Tai TY. Dose–response relationship between ischemic heart disease mortality and long-term arsenic exposure. Arteriosclerosis. Thrombosis and Vascular Biology 1996; 16: 504–510
   PubMed Web of Science ®Google Scholar
• Chen CJ, Kuo TL, Wu MM. Arsenic and cancers. Lancet 1988; i: 414–415
   Google Scholar
• Chen CJ, Hsueh YM, Lai MS, Shyu MP, Chen SY, Wu MM, Kuo TL, Tai TY. Increased prevalence of hypertension and long-term arsenic exposure. Hypertension 1995; 25: 53–60
   PubMed Web of Science ®Google Scholar
• Chiou HY, Hsueh YM, Hsieh LL, Hsu LI, Hsu YH, Hsieh FI, Wei ML, Chen HC, Yang HT, Leu LC, Chu TH, Chen-Wu C, Yang MH, Chen CJ. Arsenic methylation capacity, body retention, and null genotypes of gluathione S-transferase M1 and T1 among current arsenic-exposed residents in Taiwan. Mutation Research 1997; 386: 197–207
   PubMed Web of Science ®Google Scholar
• Do T, Gambelunghe A, Ahsan H, Graziano J, Perrin M, Slavkovich V, Parves F, Milton AH, Brandt-Rauf P. Urinary transforming growth factor-alpha in individuals exposed to arsenic in drinking water in Bangladesh. Biomarkers 2001; 6: 127–132
   PubMed Web of Science ®Google Scholar
• Ellis DL, Chow JC, King LE, Jr. Detection of urinary TGF-alpha by HPLC and western blot in patients with melanoma. Journal of Investigative Dermatology 1990; 95: 27–30
   PubMed Web of Science ®Google Scholar
• Germolec DR, Yoshida T, Gaido K, Wimer JL, Simeonova PP, Kayama F, Burieson F, Dong W, Lange RW, Luster MI. Arsenic induces over-expression of growth factors in human keratinocytes. Toxicology and Applied Pharmacology 1996; 141: 308–318
   PubMed Web of Science ®Google Scholar
• Hsu KH, Froines JR, Chen CJ. Studies of arsenic ingestion from drinking-water in Northeastern Taiwan: Chemical speciation and urinary metabolites. Arsenic exposure and health effects, CO Abernathy, RL Calderon, WR Chappell. Chapman & Hall, London 1997; 190–209
   Google Scholar
• Hutchinson J. Arsenic and cancer. British Medical Journal 1987; 2: 1280–1281
   Google Scholar
• Hutchinson J. Diseases, etc, of the skin: I. On some examples of arsenic-keratosis of the skin and of arsenic-cancer. Transactions of the Pathology Society of London 1988; 39: 352–363
   Google Scholar
• IARC. Some metals and metallic compounds. Monographs on the Evaluation of the Carcinogenesis Risk in Humans Suppl. 1980; 7: 100–103
   Google Scholar
• Jha AN, Noditi M, Nilsson R, Natarajan AT. Genotoxic effect of sodium arsenic on human cells. Mutation Research 1992; 284: 215–221
   PubMed Web of Science ®Google Scholar
• Katoh M, Inagaki H, Kurosawa-Ohsawa K, Katsuura M, Tanaka S. Detection of transformation growth factor alpha in human urine and plasma. Biochemistry and Biophysics Research Communications 1990; 167: 1065–1072
   PubMed Web of Science ®Google Scholar
• Lee TC, Tanaka N, Lamb PW, Gimer TM, Barrett JC. Induction of gene amplification by arsenic. Science 1988; 241: 79–81
   PubMed Web of Science ®Google Scholar
• Rahman MM, Chowdhury UK, Mukherjee SC, Mondal BK, Paul K, Lodh D, Biswas BK, Chanda CR, Basu GK, Saha KC, Roy S, Das R, Palit SK, Quamruzzaman Q, Chakraborti D. Chronic arsenic toxicity in Bangladesh and West Bengal India — a review and commentary. Clinical Toxicology 2001; 39: 683–700
   Web of Science ®Google Scholar
• Ridderheim M, Cajander S, Tavelin B, Stendahl U, Backstrom T. EGF/TGF-alpha and progesterone in urine of ovarian cancer patients. Anticancer Research 1994; 14: 2119–2123
   PubMed Web of Science ®Google Scholar
• Takagi H, Sharp R, Takayama H, Anver MR, Ward JM. Collaboration between growth factors and diverse chemical carcinogens in hepatocarcinogenesis of transforming growth factor a of transgenic mice. Cancer Research 1993; 53: 4329–4336
   PubMed Web of Science ®Google Scholar
• Thorgeirsson SS, Santoni-Rugui E. Transgenic mouse model carcinogenesis: interaction of c-myc with transforming growth factor a and hepatocyte growth factor in hepatocarcinogenesis. British Journal of Clinical Pharmacology 1996; 42: 43–52
   PubMed Web of Science ®Google Scholar
• Todare GJ, Marquardt H, Twardzik DR, Reynolds FH, Stephenson JR. transforming growth factors produced by viral-transformed and human tumor cells. Genes and protein in oncogenesis, H Vogel, IB Weinstein. Raven, New York, NY 1985; 165–182
   Google Scholar
• Tseng WP, Chu CM, How SW, Fong JM, Lin CS, Yeh S. Prevalence of skin cancer in an epidemic area of chronic arsenicism in Taiwan. Journal of the National Cancer Institute 1968; 40: 453–463
   PubMed Web of Science ®Google Scholar
• Vahter M, Norin H. Metabolism of 74 As-labeled trivalent and Pentavalent inorganic arsenic in mice. Environment Research 1980; 21: 446–457
   PubMed Web of Science ®Google Scholar
• Walz TM, Malm C, Wasteson A. Expression of the transforming growth factor alpha protooncogene in differentiating human promyelocytic leukemia (HL-60) cells. Cancer Research 1993; 53: 191–196
   PubMed Web of Science ®Google Scholar
• World Health Organization (WHO). Arsenic. Environmental Health Criteria No. 18. WHO, Geneva 1981
   Google Scholar
• Wu HY, Chen KP, Tseng WP, Hsu CL. Epidemiologic studies on Blackfoot disease: I. Prevalence and incidence of the disease by age, sex, occupation and geographical distribution. Memoirs of the College of Medicine National Taiwan University 1961; 7: 33–50
   Google Scholar
• Yeh YC, Tsai JF, Chuang LY, Yeh HW, Tsai JH, Florine DL, Tarn JP. Elevation of transformationing growth factor alpha and its relationship to the epidermal growth factor and alpha-fetoprotein levels in patients with hepatocellular carcinoma. Cancer Research 1987; 47: 896–901
   PubMed Web of Science ®Google Scholar
• Yu RC, Hsu KH, Chen CJ, Froines JR. Arsenic methylation capacity and skin cancer. Cancer Epidemiology Biomarkers and Prevention 2000; 9: 1259–1962
   PubMed Web of Science ®Google Scholar